Tailored doses of cytostatic improve survival rate

Researchers at Karolinska Institutet in Sweden, and colleagues at University Children's Hospital ZA1 4rich in Switzerland have managed to improve cytostatic therapy for children with the chronic immune deficiency disorder granulomatous disease prior to stem cell transplantation.

http://medicalxpress.com/news/2013-10-tailored-doses-cytostatic-survival.html